Seoul National University Hospital
Seoul, 110-744, South Korea
NCT Number: NCT01154946
The aims of this study are
* to confirm whether detrusor after-contraction (DAC) is a true contraction or not with a new approach * and to understand clinical implication of DAC
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Seoul, 110-744, South Korea
The definition of detrusor after-contraction (DAC) is usually accepted as the increase of detrusor pressure (Pdet), whether it is sudden or not, after cessation of urinary flow. The amount of increase in Pdet is sometimes included in the definition of DAC (14, 15, 20 cmH2O or at least two times the level of the maximal Pdet during the voiding phase). However, it is clear that the lack of a well-established definition may induce much bias in the interpretation of the clinical implication of DAC. The previous studies showed a wide range of prevalence.1-4 DAC seemed to occur more frequently in children and the occurrence rate usually decreased with age in urodynamic studies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 2 years (2007.Jan-2008.Dec)
no change of Pdet when patients cough could confirm that DAC was a true contraction. Because an artifact occurred when a catheter was pressed against bladder wall or urethra, no change of intravesical pressure and increase of abdominal pressure finally induced a negative deflection of Pdet and this change of Pdet could be regarded as an artifact.
Time frame: up to 2 years (2007.Jan-2008.Dec)
One-way analysis of variance and the chi-square test were performed to determine whether there was a relationship between the presence of DAC and the underlying neurogenic and non-neurogenic conditions
Seoul National University Hospital
Other
A New Approach to Clinical Implication of Detrusor After-contraction (DAC)
Acronym: DAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05820139
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06814847
Machine Learning, Voiding Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03574610
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Houston, Texas, United States
View Trial DetailsNCT05295823
Voiding Disorders, Voiding Dysfunction
New Haven, Connecticut, United States
View Trial Details